Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04205929 · ClinicalTrials.gov registry record · Phase 4
Use of Curcumin to Treat Unfavorable Bleeding Patterns in Contraceptive Implant Users
A Phase 4 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 4
- Development phase
- 58
- Enrollment target
NCT04205929 is a Phase 4 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 58 participants.
The verdict
NCT04205929, a Phase 4 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 58 participants
- Enrollment target
Study Summary
The investigators plan to study the effects of curcumin, the active ingredient in the spice turmeric, on the irregular bleeding experienced by women who use the contraceptive implant.
Interventions
- DRUG Placebo
- DRUG Curcumin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2020-04-15 |
| Est. Completion | 2023-08-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04205929
The ClinicalTrials.gov registry entry for NCT04205929 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04205929 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04205929 about?
NCT04205929 is a clinical study titled "Use of Curcumin to Treat Unfavorable Bleeding Patterns in Contraceptive Implant Users". The investigators plan to study the effects of curcumin, the active ingredient in the spice turmeric, on the irregular bleeding experienced by women who use the contraceptive implant.
What is the current status of trial NCT04205929?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 58 participants. The study started on 2020-04-15. Estimated completion is 2023-08-01.
What interventions are being tested in trial NCT04205929?
The interventions under investigation include: Placebo (DRUG), Curcumin (DRUG).
Who is sponsoring clinical trial NCT04205929?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.